2025-05-06

HUITAI Biomedicine to Present at the Respiration Innovation Summit 2025

View details

2025-03-28

Positive Topline Data | HUITAI Biomedicine Announces Successful Phase I Clinical Trial of Anti-Fibrosis Program

View details

2024-07-11

Huitai Biomedicine Announces First Healthy Subject Dosed in Phase I Trial of HTPEP-001

View details

2020-09-24

Innovative Biological anti-Fibrosis Drugs Developed in Chengdu Huitai Biomedicine Company appeared in the annual conference of the American Thoracic Society (ATS) in 2020

View details

2020-01-20

Huitai‘s second IPF International Academic conference in 2020

View details

2018-11-20

Huitai 2018 IPF Expert Academic conference

View details